{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-223985","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2026-05-14T20:06:06+00:00","discovered_at":"2026-05-14T20:08:00.231672+00:00","generated_at":"2026-05-14T21:01:21.435848+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Arcadia Q1 net loss $4.4M ($2.11/share); Zola volumes +18% YoY","bullets":["Net loss attributable to common stockholders $4.385M (EPS -$2.11) vs net income $2.599M ($1.90 EPS) in Q1 2025.","Zola coconut water unit volume +18% YoY; total revenue $1.1M down 8% due to $193k revenue reserve release in prior year.","SG&A $1.179M, lowest in public company history, down $559k YoY; cash and equivalents $0.954M vs $0.259M at year-end.","January 2026 warrant inducement generated $2.1M gross proceeds but caused $2.877M loss; company continues evaluating strategic alternatives.","Company plans new product launch fall 2026; Zola benefited from price increase at start of year."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-223985","json":"https://secwatch.observer/filing/0001193125-26-223985.json","markdown":"https://secwatch.observer/filing/0001193125-26-223985.md","text":"https://secwatch.observer/filing/0001193125-26-223985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/0001193125-26-223985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/rkda-20260514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:01:21.435848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e6eb58fa49d270f42f99188c26694b9ef84e7a0e","claim":"Arcadia Biosciences, Inc. reported financial results for first quarter of 2026.","evidence_excerpt":"On May 14, 2026 Arcadia Biosciences, Inc. (the “Company”) issued a press release announcing financial results for the first quarter of 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526223985/0001193125-26-223985-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}